Page last updated: 2024-09-05

7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Infections, Helicobacter

7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with Infections, Helicobacter in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, H; Epplein, M; Gao, YT; Lan, Q; Li, HL; Michel, A; Milne, G; Pawlita, M; Rothman, N; Shu, XO; Wang, T; Xiang, YB; Zheng, W1
Abnet, CC; Chow, WH; Dong, LM; Gao, YT; Ji, BT; Li, HL; Milne, G; Rothman, N; Shu, XO; Yang, G; Zheng, W1

Trials

1 trial(s) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Infections, Helicobacter

ArticleYear
Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009, Volume: 18, Issue:11

    Topics: Adult; Aged; Biomarkers, Tumor; Case-Control Studies; China; Cohort Studies; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Prostaglandins; Risk Factors; Stomach Neoplasms; Women's Health

2009

Other Studies

1 other study(ies) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Infections, Helicobacter

ArticleYear
A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, May-15, Volume: 64, Issue:10

    Topics: Adult; Aged; Antibodies, Bacterial; Antigens, Bacterial; Case-Control Studies; China; Chromatography, Liquid; Cohort Studies; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Logistic Models; Male; Middle Aged; Odds Ratio; Prospective Studies; Prostaglandins; Recombinant Fusion Proteins; Risk Factors; Serology; Stomach Neoplasms; Tandem Mass Spectrometry

2017